Royalty Pharma PLC RPRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
28.38UNCH (UNCH)
Volume
88,365
Close
28.38quote price arrow up+0.29 (+1.03%)
Volume
1,944,875
52 week range
25.92 - 34.74
Loading...
  • Open28.31
  • Day High28.56
  • Day Low28.10
  • Prev Close28.09
  • 52 Week High34.74
  • 52 Week High Date05/15/23
  • 52 Week Low25.92
  • 52 Week Low Date09/21/23

Key Stats

  • Market Cap16.955B
  • Shares Out597.44M
  • 10 Day Average Volume3.31M
  • Dividend0.84
  • Dividend Yield2.96%
  • Beta0.47
  • YTD % Change1.03

KEY STATS

  • Open28.31
  • Day High28.56
  • Day Low28.10
  • Prev Close28.09
  • 52 Week High34.74
  • 52 Week High Date05/15/23
  • 52 Week Low25.92
  • 52 Week Low Date09/21/23
  • Market Cap16.955B
  • Shares Out597.44M
  • 10 Day Average Volume3.31M
  • Dividend0.84
  • Dividend Yield2.96%
  • Beta0.47
  • YTD % Change1.03

RATIOS/PROFITABILITY

  • EPS (TTM)1.78
  • P/E (TTM)15.93
  • Fwd P/E (NTM)7.16
  • EBITDA (TTM)939.404M
  • ROE (TTM)12.83%
  • Revenue (TTM)2.239B
  • Gross Margin (TTM)-
  • Net Margin (TTM)53.01%
  • Debt To Equity (MRQ)94.46%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date05/16/2024
  • Div Amount0.21
  • Split Date-
  • Split Factor-

Latest On Royalty Pharma PLC

 

Profile

MORE
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya...
Pablo Legorreta
Chairman of the Board, Chief Executive Officer
Christopher Hite
Vice Chairman, Executive Vice President
Terrance Coyne
Chief Financial Officer, Executive Vice President
George Lloyd
Executive Vice President - Investments and Chief Legal Officer
Marshall Urist M.D., Ph.D.
Executive Vice President - Research and Investments
Address
110 East 59th Street
New York, NY
10022
United States

Top Peers

SYMBOLLASTCHG%CHG
UTHR
United Therapeutics Corp
264.34+0.07+0.03%
BMRN
Biomarin Pharmaceutical Inc
80.50-0.53-0.65%
CTLT
Catalent Inc
55.80-0.01-0.02%
IONS
Ionis Pharmaceuticals Inc
38.80-0.28-0.72%
BPMC
Blueprint Medicines Corp
108.05+1.35+1.27%